Literature DB >> 23506890

Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects.

Helgi B Schiöth1, Sahar Roshanbin, Maria G A Hägglund, Robert Fredriksson.   

Abstract

About 25% of all solute carriers (SLCs) are likely to transport amino acids as their primary substrate. One of the major phylogenetic clusters of amino acid transporters from the SLC family is the β-family, which is part of the PFAM APC clan. The β-family includes three SLC families, SLC32, SLC36 and SLC38 with one, four and eleven members in humans, respectively. The most well characterized genes within these families are the vesicular inhibitory amino acid transporter (VIAAT, SLC32A1), PAT1 (SLC36A1), PAT2 (SLC36A2), PAT4 (SLC36A4), SNAT1 (SLC38A1), SNAT2 (SLC38A2), SNAT3 (SLC38A3), and SNAT4 (SLC38A4). Here we review the structural characteristics and functional role of these transporters. We also mined the complete protein sequence datasets for nine different genomes to clarify the evolutionary history of the β-family of transporters. We show that all three main branches of the this family are found as far back as green algae suggesting that genes from these families existed in the early eukaryote before the split of animals and plants and that they are present in most animal species. We also address the potential of further drug development within this field highlighting the important role of these transporters in neurotransmission and transport of amino acids as nutrients.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23506890     DOI: 10.1016/j.mam.2012.07.012

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  61 in total

Review 1.  The SLC38 family of sodium-amino acid co-transporters.

Authors:  Stefan Bröer
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

2.  Semi-Mechanistic Population Pharmacokinetic Modeling of L-Histidine Disposition and Brain Uptake in Wildtype and Pht1 Null Mice.

Authors:  Xiao-Xing Wang; Yang-Bing Li; Meihua R Feng; David E Smith
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Monitoring Cell-surface N-Glycoproteome Dynamics by Quantitative Proteomics Reveals Mechanistic Insights into Macrophage Differentiation.

Authors:  Mathias Kalxdorf; Stephan Gade; H Christian Eberl; Marcus Bantscheff
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

4.  Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole.

Authors:  Jeffrey D Erickson
Journal:  J Neurochem       Date:  2017-05-18       Impact factor: 5.372

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells.

Authors:  Feifeng Song; Yongjun Hu; Yuqing Wang; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2018-01-02       Impact factor: 4.939

Review 7.  Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2016-10-31

8.  A novel role for PHT1 in the disposition of l-histidine in brain: In vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice.

Authors:  Xiao-Xing Wang; Yongjun Hu; Richard F Keep; Noriko Toyama-Sorimachi; David E Smith
Journal:  Biochem Pharmacol       Date:  2016-11-11       Impact factor: 5.858

Review 9.  Role of amino acid transporters in amino acid sensing.

Authors:  Peter M Taylor
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

Review 10.  Regulation and function of the SLC38A3/SNAT3 glutamine transporter.

Authors:  Isabel Rubio-Aliaga; Carsten A Wagner
Journal:  Channels (Austin)       Date:  2016-06-30       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.